Cancer52 are running an online patient survey, which closes on Friday 10th July. If you been affected by a rare and less common cancer – all cancers except breast, bowel, lung or prostate – either as a patient or a carer, please consider taking the survey. The online survey is anonymous and you can share honest feedback about your experiences, what worked, what didn’t, and where the opportunities are for change. Please click on the survey link: https://www.surveymonkey.com/

Cancer52 are pleased to welcome their newest member, ROS1ders UK. ROS1ders UK is a patient-led charity created to support people living with ROS1-positive cancer and their families.

The Joshua Tree is Cancer52's newest member! The Joshua Tree provide bespoke emotional health and wellbeing support for families affected by childhood cancer across the UK.

Cahonas Scotland, Scotland's only dedicated testicular cancer charity, has joined Cancer52.

We're pleased to welcome Lynch Syndrome UK as the latest charity to join Cancer52.

EGFR Positive UK joins Cancer52 as our newest member.

In this State of Nation Report: No Cancer Too Rare, Cancer52 reviews policy developments since the 2024 General Election that will shape the next 10 years of cancer services. The report also reflects on what these developments means for our priorities for the UK Government and for making rare and less common cancers a priority in national policy.

Cancer52’s newest member, The Bardo Foundation is an international childhood cancer charity founded in memory of Bernardo “Bardo” Eggesbø.

Leiomyosarcoma Research UK has joined Cancer52.

The Rare Cancers Act 2026 will prioritise long overlooked aspects of research, and has the potential to transform outcomes for those affected by rare and less common cancers.